BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30794469)

  • 1. The pharmacological management of patients with comorbid psoriasis and obesity.
    Chiricozzi A; Gisondi P; Girolomoni G
    Expert Opin Pharmacother; 2019 May; 20(7):863-872. PubMed ID: 30794469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term control of psoriasis is necessary].
    Sánchez Carazo JL; Martínez Casimiro L; Alegre de Miguel V
    Actas Dermosifiliogr; 2008 Jan; 99 Suppl 1():29-36. PubMed ID: 18341851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A global approach to psoriatic patients through PASI score and Skindex-29.
    Prignano F; Ruffo G; Ricceri F; Pescitelli L; Lotti T
    G Ital Dermatol Venereol; 2011 Feb; 146(1):47-52. PubMed ID: 21317856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis.
    Burfield L; Burden AD
    J R Coll Physicians Edinb; 2013; 43(4):334-8; quiz 339. PubMed ID: 24350319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunology of psoriasis: from basic research to the bedside].
    Gyulai R; Kemény L
    Orv Hetil; 2006 Nov; 147(46):2213-20. PubMed ID: 17396393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic therapy of psoriasis].
    Altmeyer P; Nüchel C
    Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of psoriasis and psoriatic arthritis.
    Papoutsaki M; Costanzo A
    BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
    Bronckers IMGJ; Seyger MMB; West DP; Lara-Corrales I; Tollefson M; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Philipp S; Szalai Z; Vleugels RA; Holland K; Murphy R; Baselga E; Cordoro K; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Paller AS;
    JAMA Dermatol; 2017 Nov; 153(11):1147-1157. PubMed ID: 28903160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with psoriasis.
    Croney S
    Br J Nurs; 2017 Mar; 26(5):260-262. PubMed ID: 28328264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatments in childhood psoriasis: a French multicentre study on 154 children.
    Charbit L; Mahé E; Phan A; Chiaverini C; Boralevi F; Bourrat E; Lasek A; Maruani A; Aubin F; Droitcourt C; Barbarot S; Mallet S; Mazereeuw-Hautier J; Begon E; Abasq C; Plantin P; Souillet AL; Hadj-Rabia S; Bursztejn AC;
    Br J Dermatol; 2016 May; 174(5):1118-21. PubMed ID: 26617180
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.
    Ahlehoff O; Skov L; Gislason G; Gniadecki R; Iversen L; Bryld LE; Lasthein S; Lindhardsen J; Kristensen SL; Torp-Pedersen C; Hansen PR
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1128-34. PubMed ID: 25303139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New topical treatments for psoriasis.
    Chiricozzi A; Pitocco R; Saraceno R; Nistico SP; Giunta A; Chimenti S
    Expert Opin Pharmacother; 2014 Mar; 15(4):461-70. PubMed ID: 24392930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Psoriasis.
    Smith J; Cline A; Feldman SR
    South Med J; 2017 Jan; 110(1):65-75. PubMed ID: 28052180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity.
    Chiricozzi A; Raimondo A; Lembo S; Fausti F; Dini V; Costanzo A; Monfrecola G; Balato N; Ayala F; Romanelli M; Balato A
    Expert Rev Clin Immunol; 2016 Dec; 12(12):1299-1308. PubMed ID: 27322922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic therapies in psoriasis: a new therapeutic approach.
    Gisondi P; Girolomoni G
    Autoimmun Rev; 2007 Sep; 6(8):515-9. PubMed ID: 17854741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecules and antibodies for the treatment of psoriasis: a patent review (2010-2015).
    Chiricozzi A; Saraceno R; Novelli L; Fida M; Caso F; Scarpa R; Costa L; Perricone R; Romanelli M; Chimenti S; Chimenti MS
    Expert Opin Ther Pat; 2016 Jul; 26(7):757-66. PubMed ID: 27266423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of methotrexate in patients with psoriasis.
    Kuhn A; Ruland V; Patsinakidis N; Luger TA
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S138-44. PubMed ID: 21044448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.